Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Cost, Maintenance

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Cost, Maintenance

Citius Pharmaceuticals, Inc. (CTXR) reported Cost, Maintenance of $75.00 thousand for the 1-month period ending 2023-01-31, per its 10-Q filed 2023-08-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:CostMaintenance · last filed 2023-08-14

  • 2023-01-31: Cost, Maintenance 1 month $75.00K.
  • 2022-06-30: Cost, Maintenance 1 month $90.00K.
  • 2022-01-31: Cost, Maintenance 1 month $60.00K.
  • 2021-06-30: Cost, Maintenance 1 month $90.00K.
Period endCost, Maintenance 1 month
2023-01-31$75.00K
10-Q · filed 2023-08-14
2022-06-30$90.00K
10-Q · filed 2023-05-12
2022-01-31$60.00K
10-Q · filed 2023-08-14
2021-06-30$90.00K
10-Q · filed 2023-05-12
2021-01-31$45.00K
10-Q · filed 2023-02-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36